Nicholas Adams - Bioquell Plc Group Chief Executive and Executive Director
Director
Mr. Nicholas M. T. Adams is Chief Executive, Executive Director of Bioquell PLC. He Joined the Board in May 1997 and was appointed Chief Executive in May 1998. Previously he was a Director of Corporationrationrate Finance at Barings, an investment bank, having spent nine years in Barings Corporationrationrate Finance Department both in the UK and continental Europe. He read chemistry at Durham University. since 1998.
Tenure | 26 years |
Phone | 44 1264 835 835 |
Web | http://www.bioquellplc.com |
Bioquell Plc Management Efficiency
The company has return on total asset (ROA) of 6.36 % which means that it generated a profit of $6.36 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 12.0 %, meaning that it generated $12.0 on every $100 dollars invested by stockholders. Bioquell Plc's management efficiency ratios could be used to measure how well Bioquell Plc manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
James Jones | NMI Holdings | 69 | |
William Ferry | Duluth Holdings | 76 | |
Douglas Skidmore | Cincinnati Financial | 55 | |
John Osmon | NMI Holdings | 38 | |
James Ozanne | NMI Holdings | 74 | |
Andrew Rolfe | JJill Inc | 53 | |
Andrew Cleverly | Carters | 75 | |
Michael Eck | JJill Inc | 57 | |
David Pulver | Carters | 78 | |
Mark Hipp | Carters | 58 | |
Linda ClementHolmes | Cincinnati Financial | 55 | |
Michael Embler | NMI Holdings | 53 | |
Richard Noll | Carters | 62 | |
Amy Brinkley | Carters | 64 | |
Thomas Whiddon | Carters | 66 | |
Paul Fulton | Carters | 82 | |
John Schiff | Cincinnati Financial | 71 | |
Regina Muehlhauser | NMI Holdings | 69 | |
David Osborn | Cincinnati Financial | 57 | |
William McMullen | Cincinnati Financial | 57 | |
Thomas Schiff | Cincinnati Financial | 70 |
Management Performance
Return On Equity | 12.0 | |||
Return On Asset | 6.36 |
Bioquell Plc Leadership Team
Elected by the shareholders, the Bioquell Plc's board of directors comprises two types of representatives: Bioquell Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bioquell. The board's role is to monitor Bioquell Plc's management team and ensure that shareholders' interests are well served. Bioquell Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bioquell Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ian Johnson, Non-Executive Chairman of the Board | ||
Nigel Keen, Independent Non-Executive Chairman of the Board | ||
Nicholas Adams, Group Chief Executive and Executive Director | ||
Christopher Mills, Non-Executive Director | ||
Anthony Bourne, Independent Non-Executive Director | ||
Georgina Pope, Company Secretary | ||
Michael Roller, Group Finance Director, Director | ||
Ian Carruthers, Independent Non-Executive Director | ||
Simon Constantine, Independent Non-Executive Director |
Bioquell Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc bb equity is not an easy task. Is Bioquell Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 12.0 | |||
Return On Asset | 6.36 | |||
Profit Margin | 10.40 % | |||
Operating Margin | 11.22 % | |||
Current Valuation | 138.32 M | |||
Shares Outstanding | 22.43 M | |||
Price To Earning | 41.47 X | |||
Price To Book | 4.30 X | |||
Price To Sales | 4.16 X | |||
Revenue | 40.34 M |
Pair Trading with Bioquell Plc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bioquell Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bioquell Plc will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Bioquell OTC BB Equity
If you are still planning to invest in Bioquell Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bioquell Plc's history and understand the potential risks before investing.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |